OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The network map of Elabela signaling pathway in physiological and pathological conditions
Shobha Dagamajalu, Rex Devasahayam Arokia Balaya, G. P. Suchitha, et al.
Journal of Cell Communication and Signaling (2021) Vol. 16, Iss. 1, pp. 145-154
Open Access | Times Cited: 13

Showing 13 citing articles:

Structural insight into apelin receptor-G protein stoichiometry
Yue Yang, Lier Liu, Lijie Wu, et al.
Nature Structural & Molecular Biology (2022) Vol. 29, Iss. 7, pp. 688-697
Closed Access | Times Cited: 38

Mapping growth differentiation factor-15 (GDF15)-mediated signaling pathways in cancer: insights into its role across different cancer types
Akhila Balakrishna, Jalaluddin Akbar Kandel Codi, G. P. Suchitha, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access

ELABELA-APJ-Akt/YAP Signaling Axis: A Novel Mechanism of Aerobic Exercise in Cardioprotection of Myocardial Infarction Rats
Yue Xi, Yongxia Li, Wujing Ren, et al.
Medicine & Science in Sports & Exercise (2023) Vol. 55, Iss. 7, pp. 1172-1183
Closed Access | Times Cited: 9

A promising therapeutic peptide and preventive/diagnostic biomarker for age-related diseases: The Elabela/Apela/Toddler peptide
Roberto Monastero, Daniele Magro, Marika Venezia, et al.
Ageing Research Reviews (2023) Vol. 91, pp. 102076-102076
Open Access | Times Cited: 8

Elabela Peptide: An Emerging Target in Therapeutics
Lokesh Kumar Bhatt, Maneesha Sharma, Kedar S. Prabhavalkar
Current Drug Targets (2022) Vol. 23, Iss. 14, pp. 1304-1318
Closed Access | Times Cited: 10

ERK/HIF-1α/VEGF pathway: a molecular target of ELABELA (ELA) peptide for attenuating cardiac ischemia–reperfusion injury in rats by promoting angiogenesis
Kamran Rakhshan, Masoomeh Sharifi, Fatemeh Ramezani, et al.
Molecular Biology Reports (2022) Vol. 49, Iss. 11, pp. 10509-10519
Closed Access | Times Cited: 8

The network map of urotensin-II mediated signaling pathway in physiological and pathological conditions
Rex Devasahayam Arokia Balaya, G. P. Suchitha, Akhina Palollathil, et al.
Journal of Cell Communication and Signaling (2022) Vol. 16, Iss. 4, pp. 601-608
Open Access | Times Cited: 6

Promising novel therapeutic targets for kidney disease: Emphasis on kidney-specific proteins
Tathambika Tejeswini Sen, Ajinath Kale, Maciej Lech, et al.
Drug Discovery Today (2022) Vol. 28, Iss. 2, pp. 103466-103466
Closed Access | Times Cited: 6

The apelinergic system accelerates skin repair of full-thickness excisional wounds in a diabetic murine model
Pedro Geraldes, Stéphanie Robillard, Léa Théroux, et al.
Research Square (Research Square) (2024)
Open Access

ELABELA-APJ Axis Enhances Mesenchymal Stem Cell Proliferation and Migration via the METTL3/PI3K/AKT Pathway
Dawei Xu, Jun Fu, Xingcheng Liu, et al.
Acta Naturae (2024) Vol. 16, Iss. 1, pp. 111-118
Open Access

Relationship between ELABELA/APJ and Pregnancy Disorders
晨园 赵
Advances in Clinical Medicine (2022) Vol. 12, Iss. 05, pp. 4723-4728
Closed Access

Page 1

Scroll to top